Profile for Five Prime Therapeutics, Inc. (FPRX)
« Back to company indexFPRX Chatter Timeline
Stock Ticker for FPRX
Most Active Tweeters for FPRX
| User | Tweets |
|---|---|
| @TickerReport | 8 |
| @SleekMoneycom | 6 |
| @dakotafinancial | 5 |
| @CFinancialNews | 5 |
| @emq_news | 5 |
Recent Tweets for FPRX
 |
@noritsunagirota Five Prime Therapeutics $FPRX Valuation Declined While Awm Investment Company Has Raised Holding by $600,000 ... September 25th 2017, 8:09am |
 |
@TickerReport Rhumbline Advisers Has $1.03 Million Position in Five Prime Therapeutics, Inc. $FPRX https://t.co/ekIrvD3v7m September 25th 2017, 4:09am |
|
@TickerReport Rhumbline Advisers Has $1.03 Million Position in Five Prime Therapeutics, Inc. $FPRX https://t.co/ufdVq2pJGR September 25th 2017, 4:09am |
 |
@emq_news Rhumbline Advisers Has $1.03 Million Position in Five Prime Therapeutics, Inc. $FPRX https://t.co/9nSPF51OpM September 25th 2017, 4:09am |
 |
@dakotafinancial Head-To-Head Survey: Five Prime Therapeutics $FPRX & Dermira $DERM https://t.co/Baz0NCAfLN September 24th 2017, 5:09pm |
 |
@SleekMoneycom BMO Capital Markets Reiterates Hold Rating for Five Prime Therapeutics, Inc. $FPRX https://t.co/MioTffWMJA September 24th 2017, 9:09am |
 |
@SPNewsAnalysis Five Prime Therapeutics $FPRX versus Its Rivals Critical Contrast https://t.co/BXDSYf8yPv September 24th 2017, 5:09am |
 |
@storminvestor Five Prime Therapeutics $FPRX versus Its Rivals Critical Contrast https://t.co/7sg8uRsWex September 24th 2017, 5:09am |
|
@dakotafinancial BMO Capital Markets Reiterates Hold Rating for Five Prime Therapeutics, Inc. $FPRX https://t.co/T8tjC3RRbu September 24th 2017, 3:09am |
 |
@WatchlistN Five Prime Therapeutics, Inc. $FPRX Receives Hold Rating from BMO Capital Markets https://t.co/ycUgZ6QhvY September 23rd 2017, 1:09pm |
|
@TickerReport ARK Investment Management LLC Buys 10,623 Shares of Five Prime Therapeutics, Inc. $FPRX https://t.co/vDmmk7FsQg September 23rd 2017, 11:09am |
|
@emq_news ARK Investment Management LLC Buys 10,623 Shares of Five Prime Therapeutics, Inc. $FPRX https://t.co/PCadc2Psoc September 23rd 2017, 11:09am |
|
@TickerReport ARK Investment Management LLC Buys 10,623 Shares of Five Prime Therapeutics, Inc. $FPRX https://t.co/PJxgCyvtzc September 23rd 2017, 11:09am |
 |
@intercooleronli Five Prime Therapeutics, Inc. $FPRX Stock Rating Reaffirmed by BMO Capital Markets https://t.co/1dBt3khScZ September 22nd 2017, 4:09pm |
 |
@CFinancialNews Five Prime Therapeutics, Inc. $FPRX Stock Rating Reaffirmed by BMO Capital Markets https://t.co/6OpVDX1pJ7 September 22nd 2017, 4:09pm |
 |
@RatingsNetwork Five Prime Therapeutics's hold rating reiterated at BMO Capital Markets. $39.00 PT. https://t.co/SRGymiGYuY $FPRX #FPRX September 22nd 2017, 4:09pm |
|
@SleekMoneycom Royal Bank Of Canada Begins Coverage on Five Prime Therapeutics, Inc. $FPRX https://t.co/GZbPsUzfkM September 22nd 2017, 3:09pm |
 |
@ARatings Five Prime Therapeutics Gets a Hold Rating from BMO Capital $FPRX https://t.co/3belCBl5k9 September 22nd 2017, 2:09pm |
|
@SPNewsAnalysis Contrasting Five Prime Therapeutics $FPRX & Dermira $DERM https://t.co/YU4J1aizOl September 22nd 2017, 12:09pm |
|
@storminvestor Contrasting Five Prime Therapeutics $FPRX & Dermira $DERM https://t.co/Z7e1Fa4HmH September 22nd 2017, 12:09pm |
 |
@chaffeybreeze BB Biotech AG Has $23.41 Million Stake in Five Prime Therapeutics, Inc. $FPRX https://t.co/IGKVJmEQ3w September 22nd 2017, 11:09am |
 |
@IRAMarketReport BB Biotech AG Has $23.41 Million Stake in Five Prime Therapeutics, Inc. $FPRX https://t.co/lTMkirVfEC September 22nd 2017, 11:09am |
 |
@finboxio Five Prime Therapeutics, Inc. $FPRX cashflow analyses imply stock's 39% undervalued https://t.co/NtrZ3NIi01 https://t.co/NbOnf3kWdz September 22nd 2017, 7:09am |
|
@IRAMarketReport Five Prime Therapeutics, Inc. $FPRX Position Decreased by Zurcher Kantonalbank Zurich Cantonalbank https://t.co/lNX4tk7UW3 September 22nd 2017, 5:09am |
|
@chaffeybreeze Five Prime Therapeutics, Inc. $FPRX Position Decreased by Zurcher Kantonalbank Zurich Cantonalbank https://t.co/Lc16dBldsT September 22nd 2017, 5:09am |
|
@SPNewsAnalysis Head to Head Review: Five Prime Therapeutics $FPRX and Its Rivals https://t.co/UxYsdk74CI September 22nd 2017, 3:09am |
|
@storminvestor Head to Head Review: Five Prime Therapeutics $FPRX and Its Rivals https://t.co/rMq53a0DFT September 22nd 2017, 3:09am |
 |
@GNWLive Five Prime Therapeutics to Present at the LEERINK Partners Roundtable Series: Rare Disease & Immuno- $FPRX https://t.co/Zmb9dRRVID September 21st 2017, 9:09am |
|
@SleekMoneycom Five Prime Therapeutics $FPRX & Its Peers Critical Comparison https://t.co/ZrmuSdUV8o September 21st 2017, 7:09am |
 |
@biotrader98 RT @jjgiablue: $FPRX-Cowen expects p1 data on cabiralizumab/Opdivo combo at SITC mtg in early Nov. Sees potential in NSCLC and Renal cancer. September 21st 2017, 7:09am |
|
@intercooleronli Five Prime Therapeutics $FPRX & Its Peers Critical Comparison https://t.co/Xps7gN5tIO September 21st 2017, 6:09am |
|
@dakotafinancial Five Prime Therapeutics $FPRX & Its Peers Critical Comparison https://t.co/6D2XBaLS1P September 21st 2017, 6:09am |
|
@CFinancialNews Five Prime Therapeutics $FPRX & Its Peers Critical Comparison https://t.co/zPf2CVYYzJ September 21st 2017, 6:09am |
|
@SleekMoneycom Somewhat Favorable News Coverage Somewhat Unlikely to Affect Five Prime Therapeutics $FPRX Share Price https://t.co/fHVf6HZhcY September 21st 2017, 12:09am |
 |
@jjgiablue $FPRX-Cowen expects p1 data on cabiralizumab/Opdivo combo at SITC mtg in early Nov. Sees potential in NSCLC and Renal cancer. September 20th 2017, 11:09pm |
 |
@1LuckyJimmy FPRX +0.96 total advance today 10:24 ET. Five Prime Thera $FPRX 36.29 Stock hit a High of 36.50 and 35.33 Low https://t.co/5FsOwuTEqV September 20th 2017, 11:09am |
 |
@tgtxdough BMO First Look at SITC Titles $FPRX Cabira expect confirmation of late-breaker presentation of Phase 1/2 data for Cabira + Opdivo in October September 20th 2017, 6:09am |
|
@intercooleronli Five Prime Therapeutics $FPRX and Its Peers Critical Review https://t.co/F6Zo9fG1hV September 19th 2017, 2:09pm |
|
@dakotafinancial Five Prime Therapeutics $FPRX and Its Peers Critical Review https://t.co/G1H6VQMS9f September 19th 2017, 2:09pm |
|
@CFinancialNews Five Prime Therapeutics $FPRX and Its Peers Critical Review https://t.co/2bA63yf7fq September 19th 2017, 2:09pm |
 |
@TheMarketsDaily Artal Group S.A. Acquires Shares of 150,000 Five Prime Therapeutics, Inc. $FPRX https://t.co/ilzb195DRV September 19th 2017, 11:09am |
|
@TickerReport Five Prime Therapeutics, Inc. $FPRX Shares Sold by Capital Fund Management S.A. https://t.co/R1E1KSmjnM September 19th 2017, 9:09am |
|
@emq_news Five Prime Therapeutics, Inc. $FPRX Shares Sold by Capital Fund Management S.A. https://t.co/VuLwyNFem6 September 19th 2017, 9:09am |
|
@TickerReport Five Prime Therapeutics, Inc. $FPRX Shares Sold by Capital Fund Management S.A. https://t.co/hCxACsos6q September 19th 2017, 9:09am |
|
@noritsunagirota Five Prime Therapeutics $FPRX At $36.73 Forms Bottom https://t.co/9Da7M0GJdy September 19th 2017, 6:09am |
 |
@livetradepro $FPRX Could go higher but a little leary of that downtrending 200 day moving average. https://t.co/Dg3j2M8A4a September 19th 2017, 5:09am |
 |
@biotech_sector #FivePrime Therapeutics Inc Pharmaceuticals Healthcare Deals and Alliances Profile Repor... Read more: https://t.co/809hcmAdVs $FPRX September 18th 2017, 5:09pm |
 |
@wosaikeneriki Five Prime Therapeutics $FPRX Holder Ecor1 Capital Has Upped Its Stake by $605,000 as Shares Declined ... September 18th 2017, 3:09pm |
|
@WatchlistN Royal Bank Of Canada Begins Coverage on Five Prime Therapeutics, Inc. $FPRX https://t.co/MLNZ7gqlPn September 18th 2017, 6:09am |
|
@dakotafinancial Five Prime Therapeutics $FPRX Receives Media Impact Score of 0.18 https://t.co/g04mpjCpxa September 18th 2017, 4:09am |
Contact © thinkBiotech LLC 2004 - 2017. All rights reserved.